Hand eruption after intravenous administration of bevacizumab

J Eur Acad Dermatol Venereol. 2011 Feb;25(2):238-9. doi: 10.1111/j.1468-3083.2010.03708.x. Epub 2010 May 7.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / secondary
  • Administration, Topical
  • Allopurinol / administration & dosage
  • Allopurinol / therapeutic use
  • Angiogenesis Inhibitors / administration & dosage
  • Angiogenesis Inhibitors / adverse effects*
  • Angiogenesis Inhibitors / therapeutic use
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Colonic Neoplasms / drug therapy
  • Colonic Neoplasms / pathology
  • Drug Eruptions / diagnosis*
  • Drug Eruptions / drug therapy
  • Drug Eruptions / etiology*
  • Free Radical Scavengers / administration & dosage
  • Free Radical Scavengers / therapeutic use
  • Humans
  • Injections, Intravenous
  • Liver Neoplasms / drug therapy
  • Liver Neoplasms / secondary
  • Male
  • Middle Aged
  • Ointments
  • Treatment Outcome

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Free Radical Scavengers
  • Ointments
  • Bevacizumab
  • Allopurinol